Literature DB >> 18365939

"Research chemicals": tryptamine and phenethylamine use among high-risk youth.

Bill Sanders1, Stephen E Lankenau, Jennifer Jackson Bloom, Dodi Hathazi.   

Abstract

Tryptamines and phenethylamines are two broad categories of psychoactive substances with a long history of licit and illicit use. Profiles of users of recently emerging tryptamines and phenethylamines are nonexistent, however, since surveillance studies do not query the use of these substances. This manuscript describes the types, modes of administration, onset of use, and context of use of a variety of lesser known tryptamines and phenethylamines among a sample of high-risk youth. Findings are based upon in-depth interviews with 42 youth recruited in public settings in Los Angles during 2005 and 2006 as part of larger study examining health risks associated with injecting ketamine. Youth reported that their use of tryptamines and phenethylamines was infrequent, spontaneous, and predominately occurred at music venues, such as festivals, concerts, or raves. Several purchased a variety of these "research chemicals" from the Internet and used them in private locations. While many described positive experiences, reports of short-term negative health outcomes included nausea, vomiting, diarrhea, disorientations, and frightening hallucinations. These findings, based upon pilot study data, move toward an epidemiology of tryptamine and phenethylamine use among high-risk youth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365939      PMCID: PMC2536767          DOI: 10.1080/00952990701202970

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  25 in total

Review 1.  Do hallucinogens cause residual neuropsychological toxicity?

Authors:  J H Halpern; H G Pope
Journal:  Drug Alcohol Depend       Date:  1999-02-01       Impact factor: 4.492

2.  Analysis of street drugs in seized material without primary reference standards.

Authors:  Suvi Laks; Anna Pelander; Erkki Vuori; Elisa Ali-Tolppa; Erkki Sippola; Ilkka Ojanperä
Journal:  Anal Chem       Date:  2004-12-15       Impact factor: 6.986

3.  Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.

Authors:  Brian Vastag
Journal:  Science       Date:  2005-04-15       Impact factor: 47.728

4.  Can psychedelics have a role in psychiatry once again?

Authors:  Ben Sessa
Journal:  Br J Psychiatry       Date:  2005-06       Impact factor: 9.319

5.  Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.

Authors:  Helena Carmo; Jan G Hengstler; Douwe de Boer; Michael Ringel; Fernando Remião; Félix Carvalho; Eduarda Fernandes; Lesseps A dos Reys; Franz Oesch; Maria de Lourdes Bastos
Journal:  Toxicology       Date:  2005-01-05       Impact factor: 4.221

6.  Patterns of polydrug use among ketamine injectors in New York City.

Authors:  Stephen E Lankenau; Michael C Clatts
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

7.  Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine.

Authors:  Michael S Jacob; David E Presti
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

8.  A foxy intoxication.

Authors:  John M Wilson; Frank McGeorge; Susan Smolinske; Robert Meatherall
Journal:  Forensic Sci Int       Date:  2005-02-10       Impact factor: 2.395

9.  The use of electronic debit cards in longitudinal data collection with geographically mobile drug users.

Authors:  Don C Des Jarlais; Theresa E Perlis; Joy M Settembrino
Journal:  Drug Alcohol Depend       Date:  2005-01-07       Impact factor: 4.492

10.  From home to street: understanding young people's transitions into homelessness.

Authors:  Justeen Hyde
Journal:  J Adolesc       Date:  2005-04-19
View more
  10 in total

1.  A TYPOLOGY OF DRUG-RELATED OFFENDING AMONG YOUNG HOMELESS INJECTION DRUG USERS.

Authors:  Bill Sanders; Stephen E Lankenau; Jennifer Jackson Bloom; Dodi S Hathaz
Journal:  J Drug Issues       Date:  2009

2.  Prevalence and Patterns of Prescription Drug Misuse among Young Ketamine Injectors.

Authors:  Stephen E Lankenau; Bill Sanders; Jennifer Jackson Bloom; Dodi S Hathazi; Erica Alarcon; Stephanie Tortu; Michael Clatts
Journal:  J Drug Issues       Date:  2007

3.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

4.  THE FIRST INJECTION EVENT: DIFFERENCES AMONG HEROIN, METHAMPHETAMINE, COCAINE, AND KETAMINE INITIATES.

Authors:  Stephen E Lankenau; Karla D Wagner; Jennifer Jackson Bloom; Bill Sanders; Dodi Hathazi; Charles Shin
Journal:  J Drug Issues       Date:  2010

Review 5.  2C or not 2C: phenethylamine designer drug review.

Authors:  Be Vang Dean; Samuel J Stellpflug; Aaron M Burnett; Kristin M Engebretsen
Journal:  J Med Toxicol       Date:  2013-06

6.  Fatal toxic leukoencephalopathy secondary to overdose of a new psychoactive designer drug 2C-E ("Europa").

Authors:  Justin Sacks; M Jordan Ray; Sue Williams; Michael J Opatowsky
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-10

7.  Pregnancy and sexual health among homeless young injection drug users.

Authors:  Dodi Hathazi; Stephen E Lankenau; Bill Sanders; Jennifer Jackson Bloom
Journal:  J Adolesc       Date:  2008-08-09

8.  Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California.

Authors:  Karla D Wagner; Richard F Armenta; Alexis M Roth; Jane C Maxwell; Jazmine Cuevas-Mota; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2014-05-27       Impact factor: 4.492

Review 9.  Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.

Authors:  Cristina Miliano; Giovanni Serpelloni; Claudia Rimondo; Maddalena Mereu; Matteo Marti; Maria Antonietta De Luca
Journal:  Front Neurosci       Date:  2016-04-19       Impact factor: 4.677

Review 10.  1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

Authors:  Sylvana Vilca-Melendez; Malin V Uthaug; Julian L Griffin
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.